Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease

BACKGROUND AND AIMS: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD. METHODS: 45 CF patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rath, Timo, Hage, Lisa, Kügler, Marion, Menendez Menendez, Katrin, Zachoval, Reinhart, Naehrlich, Lutz, Schulz, Richard, Roderfeld, Martin, Roeb, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597583/
https://www.ncbi.nlm.nih.gov/pubmed/23516586
http://dx.doi.org/10.1371/journal.pone.0058955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597583/
https://www.ncbi.nlm.nih.gov/pubmed/23516586
http://dx.doi.org/10.1371/journal.pone.0058955

Ejemplares similares